The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


The Journal of Immunology, 2007, 178, 6984 -6993
Copyright © 2007 by The American Association of Immunologists, Inc.

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chang, C. L.-T.
Right arrow Articles by Yang, W.-C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chang, C. L.-T.
Right arrow Articles by Yang, W.-C.

Cytopiloyne, a Polyacetylenic Glucoside, Prevents Type 1 Diabetes in Nonobese Diabetic Mice1

Cicero Lee-Tian Chang*,{ddagger}, Shu-Lin Chang*,{dagger}, Yi-Mei Lee*, Yi-Ming Chiang*, Da-Yung Chuang*,{ddagger}, Hui-Kai Kuo* and Wen-Chin Yang2,*,{ddagger}

* Agricultural Biotechnology Research Center, Academia Sinica, Taiwan, Republic of China; {dagger} Department of Biological Science and Technology, National Chiao Tung University, Taiwan, Republic of China; and {ddagger} Department of Veterinary Medicine/Department of Life Science, National Chung Hsing University, Taiwan, Republic of China

Some polyacetylenes from the plant Bidens pilosa have been reported to treat diabetes. In this study, we report that the cytopiloyne from B. pilosa, which is structurally different from the above-mentioned polyacetylenes and inhibits CD4+ T cell proliferation, effectively prevents the development of diabetes in nonobese diabetic mice as evidenced by a normal level of blood glucose and insulin and normal pancreatic islet architecture. Cytopiloyne also suppresses the differentiation of type 1 Th cells but promotes that of type 2 Th cells, which is consistent with it enhancing GATA-3 transcription. Also, long-term application of cytopiloyne significantly decreases the level of CD4+ T cells inside pancreatic lymph nodes and spleens but does not compromise total Ab responses mediated by T cells. Coculture assays imply that this decrease in CD4+ T cells involves the Fas ligand/Fas pathway. Overall, our results suggest that cytopiloyne prevents type 1 diabetes mainly via T cell regulation.

The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 This work was supported by grants (NSC91-2320-B-001-056, NSC92-2320-B-001-034, NSC93-2320-B-001-008, and 94F002-2) from the National Science Council and Academia Sinica, Taiwan, Republic of China.

2 Address correspondence and reprint requests to Dr. Wen-Chin Yang, Agricultural Biotechnology Research Center, Academia Sinica, 128, Academia Road, Section 2, Nankang 115, Taipei, Taiwan, Republic of China. E-mail address: wcyang{at}gate.sinica.edu.tw

3 Abbreviations used in this paper: FasL, Fas ligand; AU, arbitrary unit.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2007 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2007 by The American Association of Immunologists, Inc. All rights reserved.